I serve the interests of medical technology company decision-makers, venture-capitalists, and others with interests in medtech producing worldwide analyses of medical technology markets for my audience of mostly medical technology companies (but also rapidly growing audience of biotech, VC, and other healthcare decision-makers). I have a small staff and go to my industry insiders (or find new ones as needed) to produce detailed, reality-grounded analyses of current and potential markets and opportunities. I am principally interested in those core clinical applications served by medical devices, which are expanding to include biomaterials, drug-device hybrids and other non-device technologies either competing head-on with devices or being integrated with devices in product development. The effort and pain of making every analysis global in scope is rewarded by my audience's loyalty, since in the vast majority of cases they too have global scope in their businesses.Specialties: Business analysis through syndicated reports, and select custom engagements, on medical technology applications and markets in general/abdominal/thoracic surgery, interventional cardiology, cardiothoracic surgery, patient monitoring/management, wound management, cell therapy, tissue engineering, gene therapy, nanotechnology, and others.
183 Articles

Sealants, Glues, Hemostatis in Orthopaedic Applications

Opportunities for sealants, hemostasis, and closure products abound in the orthopedics field…

PatrickDriscoll PatrickDriscoll

Obesity and its Growing Prevalence Globally

Overweight and obesity were once considered a problem only in high-income countries.…

PatrickDriscoll PatrickDriscoll

Obesity Devices Gain From Drug Woes

It is a repeated theme in the history of medtech development. Drugs…

PatrickDriscoll PatrickDriscoll